Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Clearmind Medicine Inc. (CMND)

NASDAQ

$0.84

$-0.00

(-0.47%)

Pre-Market

Clearmind Medicine Inc. (CMND) Live Price Chart

Last updated: ⁦2026-09-16 10:31:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Clearmind Medicine Inc. (CMND) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $0.84, with a market capitalisation of $1.40M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.83 to $524.00. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.40M
Open	$0.85
Day's High	$73,200.00
Day's Low	$0.83
Previous Close	$0.86
Volume	3.06K
Average Volume	777.48K
P/E Ratio	--
52-Week High	$524.00
52-Week Low	$0.83
Dividend Yield	--
Earnings Date	--

Clearmind Medicine Inc. (CMND) Pre-Market Stock Price

Clearmind Medicine Inc. (CMND) is trading at $0.84 in pre-market trading as of 2026-09-16 10:22:00, down 2.35% ($0.02) from the previous close of $0.86

Pre-market trading shows how investors are pricing CMND before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

Clearmind Medicine Inc. (CMND) 7-Day Stock Price Change

Over the past seven days, Clearmind Medicine Inc. (CMND) moved from $1.16 to $0.84, representing a decline of 27.24% ($0.32).

The stock traded between $0.83 and $1.56 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 2.81 million shares, up versus the previous seven-day period, indicating higher trading activity.

CMND 52-Week Price Position

Position in Range: 0.0%

52W Low$0.83

52W High$524.00

CMND is currently trading at $0.84, placing it 0.0% of the way from its 52-week low of $0.83 to its 52-week high of $524.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Clearmind Medicine Inc. (CMND)?

Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.

Clearmind Medicine Inc. Information

Employees	2
Exchange	NASDAQ
Company Website	https://www.clearmindmedicine.com

How to Buy Clearmind Medicine Inc. (CMND) Stock on MEXC

Eligible investors can buy real shares of Clearmind Medicine Inc. (CMND) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CMND and Place Your Order

Open the RealStocks trading page and search for CMND. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Clearmind Medicine Inc. (CMND) stock price today?

Clearmind Medicine Inc. (CMND) is currently trading at $ 0.84, down 2.35% ($0.02) from the previous close of $ 0.86. Intraday prices update in real time during regular trading hours.

2.Is CMND stock going up or down today?

As of 2026-09-16 10:22:00, CMND is trading at $ 0.84, down 2.35% ($0.02) from its previous close of $ 0.86. The stock has traded between $ 0.83 and $ 73,200.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is CMND pre-market price?

As of 2026-09-16 10:22:00, CMND is trading at $ 0.84 in pre-market trading, down 2.35% ($0.02) from the previous close of $ 0.86. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CMND after-hours price?

As of 2026-09-16 10:22:00, CMND is trading at $ 0.85 in after-hours trading, down 1.77% ($0.02) from the regular-session close of $ 0.86. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CMND stock trading now?

CMND trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CMND sit relative to its 52-week high and low?

Over the past 52 weeks, CMND has traded between a low of $ 0.83 and a high of $ 524.00. At $ 0.84, the stock is positioned 0.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Clearmind Medicine Inc. in?

Clearmind Medicine Inc. (CMND) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Clearmind Medicine Inc.'s market capitalisation and where is it listed?

Clearmind Medicine Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 1.40M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CMND valued in terms of P/E ratio and EPS?

CMND trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Clearmind Medicine Inc. pay a dividend?

Clearmind Medicine Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.